DAWN icon

Day One Biopharmaceuticals
DAWN

Overview Fund Activity

33 hedge funds and large institutions have $401M invested in Day One Biopharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+33
Holders Change %
–
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RCM
RA Capital Management
Massachusetts
$113M
2
Fidelity Investments
Fidelity Investments
Massachusetts
$52.7M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$33.4M
4
Viking Global Investors
Viking Global Investors
Connecticut
$30.5M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
$27.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
ECM
26
ExodusPoint Capital Management
New York
$213K +$213K +9,372 New
MS
27
Maven Securities
Jersey
$210K +$210K +9,000 New
BlackRock
28
BlackRock
New York
$99K +$99K +4,372 New
Morgan Stanley
29
Morgan Stanley
New York
$54K +$54K +2,374 New
CAL
30
Capital Analysts LLC
Pennsylvania
$17K +$17K +750 New
Bank of America
31
Bank of America
North Carolina
$16K +$16K +700 New
JPMorgan Chase & Co
32
JPMorgan Chase & Co
New York
$1K +$1K +54 New
1
2